Clinical Trial Update: A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI) [Phase 3]

View source ↗

Summary

Phase 3 study in Japanese patients with moderately to severely active rheumatoid arthritis evaluating added sarilumab to methotrexate; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Sarilumab (sarilumab)

Snippet

Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2018-01-30